ERG and acute myeloid leukemia: In the future, to fully validate the ERG IHC in AML diagnostic workup, we hope to get another laboratory to validate ERG in their patient population. Further studies utilizing anti-ERG flow cytometry could assist in determining ERG specificity, and a more comprehensive assessment of ERG in normal bone marrow specimens will help determine the role of ERG IHC in the future.